title: Prospective, observational study of plasma-derived factor VIII/von Willebrand factor in immune tolerance induction: the PRISM registry.
authors.affiliation: Puget Sound Blood Center, Seattle, WA, USA.
authors.forename: R
authors.initials: R
authors.lastname: Kruse-Jarres
authors.affiliation: RTI Health Solutions, Research Triangle Park, NC, USA.
authors.forename: A
authors.initials: A
authors.lastname: Gilsenan
authors.affiliation: Grifols, Research Triangle Park, NC, USA.
authors.forename: J
authors.initials: J
authors.lastname: Spears
authors.affiliation: RTI Health Solutions, Research Triangle Park, NC, USA.
authors.forename: J A
authors.initials: JA
authors.lastname: Kaye
mesh_terms: D004338:Drug Combinations; D005169:Factor VIII / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*; D006467:Hemophilia A / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology*; D006801:Humans; D007108:Immune Tolerance; D007518:Isoantibodies / Q000276:immunology; D012042:Registries; D016896:Treatment Outcome; D014841:von Willebrand Factor / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D004338:Drug Combinations; D007518:Isoantibodies; C509423:factor VIII, von Willebrand factor drug combination; D014841:von Willebrand Factor; D005169:Factor VIII